Heather Ann Rocha, PA-C
Physician Assistant · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Heather Ann Rocha’s office at (650) 814-4143 to ask if they take your plan before you enroll.
California Medical Board record
Licence C21990 · Delinquent
Licence status: Delinquent · since 1960 · expires 2025-10-31 · University of Pennsylvania School of Medicine.
License renewal fee has not been paid. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$2,007 in 2022
Medicaid paid $2,007 for 13 billed services this clinician did in 2022, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 13 | $2,007 |
| 2022 | 13 | 1 | 13 | $2,007 |
| 2021 | 405 | 14 | 34 | $25,287 |
| 2020 | 12 | 1 | 12 | $1,536 |
| 2019 | 924 | 11 | 51 | $90,390 |
| 2018 | 41 | 2 | 14 | $5,746 |
See the largest Medicaid services in earlier years
2021
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 62 | $9,430 |
| Short return visit | 25 | $3,860 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 62 | $2,480 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 15 | $2,316 |
| Short return visit (20+ min) | 12 | $1,851 |
| SARSCOV CORONAVIRUS AG IA | 34 | $1,745 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 42 | $1,680 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; single dose | 17 | $640 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose | 21 | $560 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 64 | $502 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 13 | $224 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 12 | $0 |
2020
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $1,536 |
2019
| Short return visit (20+ min) | 239 | $35,850 |
| Clinic visit/encounter, all-inclusive | 158 | $18,459 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 92 | $13,591 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 70 | $10,618 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 29 | $4,296 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 26 | $3,944 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; adolescent (age 12 through 17 years) | 15 | $2,081 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 48 | $625 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 165 | $605 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 46 | $323 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 36 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 27 | $3,654 |
| Short return visit (20+ min) | 14 | $2,092 |
Drugs they prescribed that Part D paid
$5,415
Pharmacies billed $5,415 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 213) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
198 generic and 15 brand-name prescriptions · $5,415 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydroxyzine Pamoate | 11 | $73 | $7 |
| Levothyroxine | 12 | $41 | $3 |
| Atorvastatin | 13 | $38 | $3 |
| Lisinopril | 13 | $34 | $3 |
| Amlodipine Besylate | 12 | $32 | $3 |
Year by year
| 2024 | 213 | 33 | 0% (0) | 7% | $5,415 |
| 2023 | 672 | 98 | 0% (0) | None | $111,834 |
| 2022 | 251 | 61 | 0% (0) | None | $28,159 |
| 2021 | 145 | 20 | 0% (0) | 10% | $7,733 |
| 2020 | 389 | 59 | 0% (0) | 12% | $22,870 |
| 2019 | 869 | 96 | 0% (0) | 19% | $62,234 |
| 2018 | 143 | 34 | 0% (0) | None | $6,166 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Trelegy Ellipta | 23 | $15,281 | $664 |
| Albuterol Sulfate Hfa | 15 | $1,124 | $75 |
| Atorvastatin | 47 | $691 | $15 |
| Omeprazole | 28 | $466 | $17 |
| Amlodipine Besylate | 43 | $429 | $10 |
| Levothyroxine | 25 | $160 | $6 |
| Meloxicam | 16 | $160 | $10 |
| Metoprolol | 11 | $109 | $10 |
| Lisinopril | 23 | $104 | $5 |
| Baclofen | 15 | $97 | $6 |
| Simvastatin | 13 | $88 | $7 |
| Hydrochlorothiazide | 11 | $38 | $3 |
2022: 3 drugs
| Atorvastatin | 23 | $363 | $16 |
| Amlodipine Besylate | 40 | $362 | $9 |
| Omeprazole | 11 | $250 | $23 |
2021: 6 drugs
| Atorvastatin | 15 | $277 | $18 |
| Levetiracetam | 12 | $265 | $22 |
| Doxazosin Mesylate | 12 | $148 | $12 |
| Losartan | 13 | $43 | $3 |
| Clopidogrel | 12 | $35 | $3 |
| Amlodipine Besylate | 14 | $20 | $1 |
2020: 12 drugs
| Colchicine | 11 | $1,771 | $161 |
| Esomeprazole Magnesium | 14 | $867 | $62 |
| Doxazosin Mesylate | 12 | $271 | $23 |
| Amlodipine Besylate | 51 | $268 | $5 |
| Levetiracetam | 12 | $253 | $21 |
| Bupropion Hcl Sr | 11 | $209 | $19 |
| Lisinopril | 21 | $138 | $7 |
| Clopidogrel | 12 | $133 | $11 |
| Atorvastatin | 23 | $114 | $5 |
| Furosemide | 19 | $59 | $3 |
| Metoprolol | 12 | $49 | $4 |
| Losartan | 12 | $38 | $3 |
2019: 21 drugs
| Pravastatin | 24 | $815 | $34 |
| Albuterol Sulfate Hfa | 15 | $738 | $49 |
| Potassium Chloride | 12 | $468 | $39 |
| Atorvastatin | 28 | $458 | $16 |
| Glipizide Er | 20 | $442 | $22 |
| Doxazosin Mesylate | 18 | $352 | $20 |
| Amlodipine Besylate | 70 | $334 | $5 |
| Levothyroxine | 17 | $309 | $18 |
| Triamterene-Hydrochlorothiazid | 34 | $290 | $9 |
| Lisinopril | 38 | $272 | $7 |
| Ranitidine | 12 | $203 | $17 |
| Quinapril | 16 | $202 | $13 |
| Gabapentin | 11 | $192 | $17 |
| Omeprazole | 13 | $161 | $12 |
| Metformin | 31 | $160 | $5 |
| Losartan | 21 | $159 | $8 |
| Furosemide | 31 | $151 | $5 |
| Metoprolol | 20 | $132 | $7 |
| Lovastatin | 14 | $97 | $7 |
| Simvastatin | 15 | $92 | $6 |
| Hydrochlorothiazide | 22 | $86 | $4 |
2018: 1 drug
| Amlodipine Besylate | 13 | $24 | $2 |
Money from drug and device companies
$56 in 2023
| 2023 | 2 | 3 | None | $56 |
| 2022 | 3 | 3 | None | $46 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Leqvio | $37 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $18 | 1 payment
|
See all 3 published payments
| Exact Sciences | Meals · 2023-06-01 | Cologuard Collection Kit | $18 |
| Novartis Pharmaceuticals | Meals · 2023-04-06 | Leqvio | $21 |
| Novartis Pharmaceuticals | Meals · 2023-03-14 | Entresto | $16 |
See earlier years (2022)
2022: $46
| Organon | Nexplanon | $17 | 1 payment
|
| Novo Nordisk | Ozempic | $16 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $13 | 1 payment
|
Professional record
- NPI
- 1841447893
- Licence
- CA 19842, CA 21990, MA 2594, VA 0117005308California C21990: Delinquent · expires 2025-10-31
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Federal specialty code 227900000X (227900000X)
- Mailing address
- Po Box 3451, Waquoit, MA, 02536
- NPI first listed
- 2008-08-21
- NPI last updated
- 2009-07-22
This is when the NPI record was last certified, not a medical board exam.